Trials / Unknown
UnknownNCT01424371
Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs)
A Case-Control Study to Evaluate the Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine in the Elderly Aged ≥65 Years.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Fraser Health · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
This study explores the hypothesis that the use of an adjuvanted influenza vaccine in the elderly will produce greater vaccine effectiveness in their group.
Detailed description
To evaluate the effectiveness of adjuvanted trivalent inactivated influenza vaccine in the elderly (aged ≥ 65 years) through the reduction in relative risk of microbiologically confirmed influenza illness
Conditions
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-04-01
- Completion
- 2013-06-01
- First posted
- 2011-08-29
- Last updated
- 2012-10-01
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01424371. Inclusion in this directory is not an endorsement.